These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 16225630)

  • 21. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
    Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
    Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
    [No Abstract]   [Full Text] [Related]  

  • 22. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.
    Wendling J; Descamps V; Grossin M; Marcellin P; Le Bozec P; Belaich S; Crickx B
    Arch Dermatol; 2002 Apr; 138(4):546-7. PubMed ID: 11939833
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases.
    Lübbe J; Kerl K; Negro F; Saurat JH
    Br J Dermatol; 2005 Nov; 153(5):1088-90. PubMed ID: 16225644
    [No Abstract]   [Full Text] [Related]  

  • 24. Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α.
    Zonta E; Chiarion V; Zarian H; Peserico A; Alaibac M
    Melanoma Res; 2012 Jun; 22(3):284-5. PubMed ID: 22543678
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.
    Mistry N; Shapero J; Crawford RI
    Can J Gastroenterol; 2009 Oct; 23(10):677-83. PubMed ID: 19826642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.